February 12, 2018 / 12:13 PM / 11 days ago

BRIEF-Medicenna Therapeutics Corp Reports Qtrly Loss Per Share $0.09

Feb 12 (Reuters) - Medicenna Therapeutics Corp:

* MEDICENNA THERAPEUTICS CORP - QTRLY LOSS PER SHARE $0.09

* MEDICENNA THERAPEUTICS CORP - ENDED QUARTER WITH TOTAL AVAILABLE FUNDING OF APPROXIMATELY $14.5 MILLION, ENOUGH TO FUND OPERATIONS INTO Q1 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below